108 related articles for article (PubMed ID: 31657617)
1. Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Colon Cancer.
Li B; Zhu FC; Yu SX; Liu SJ; Li BY
Cancer Biother Radiopharm; 2020 Feb; 35(1):50-57. PubMed ID: 31657617
[No Abstract] [Full Text] [Related]
2. Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Tongue Squamous Cell Carcinoma.
Liu Y; Li RH; Ren G; Jiang J
Biomed Res Int; 2020; 2020():6387545. PubMed ID: 32090103
[TBL] [Abstract][Full Text] [Related]
3. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
4. KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression.
Yu Y; Wang XY; Sun L; Wang YL; Wan YF; Li XQ; Feng YM
Carcinogenesis; 2014 Jun; 35(6):1416-25. PubMed ID: 24626146
[TBL] [Abstract][Full Text] [Related]
6. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.
Zhai M; Miao J; Zhang R; Liu R; Li F; Shen Y; Wang T; Xu X; Gao G; Hu J; He A; Bai J
J Cancer Res Clin Oncol; 2024 May; 150(5):239. PubMed ID: 38713252
[TBL] [Abstract][Full Text] [Related]
7. A novel long non-coding RNA from the HOXA6-HOXA5 locus facilitates colon cancer cell growth.
Saijo S; Kuwano Y; Tange S; Rokutan K; Nishida K
BMC Cancer; 2019 Jun; 19(1):532. PubMed ID: 31159758
[TBL] [Abstract][Full Text] [Related]
8. High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
Zhang Z; Xie H; Zhu S; Chen X; Yu J; Shen T; Li X; Shang Z; Niu Y
Med Sci Monit; 2018 Nov; 24():8190-8197. PubMed ID: 30427826
[TBL] [Abstract][Full Text] [Related]
9. shRNA-mediated XRCC2 gene knockdown efficiently sensitizes colon tumor cells to X-ray irradiation in vitro and in vivo.
Wang Q; Wang Y; Du L; Xu C; Sun Y; Yang B; Sun Z; Fu Y; Cai L; Fan S; Fan F; Liu Q
Int J Mol Sci; 2014 Jan; 15(2):2157-71. PubMed ID: 24481064
[TBL] [Abstract][Full Text] [Related]
10. ShRNA-mediated gene silencing of heat shock protein 70 inhibits human colon cancer growth.
Zhong MA; Zhang H; Qi XY; Lu AG; You TG; Gao W; Guo XL; Zhou ZQ; Yang Y; Wang CJ
Mol Med Rep; 2011; 4(5):805-10. PubMed ID: 21725599
[TBL] [Abstract][Full Text] [Related]
11. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease.
Feng YH; Wu CL; Tsao CJ; Chang JG; Lu PJ; Yeh KT; Uen YH; Lee JC; Shiau AL
Cancer Biol Ther; 2011 Jan; 11(1):111-21. PubMed ID: 21099344
[TBL] [Abstract][Full Text] [Related]
13. Silencing of voltage-gated potassium channel KV9.3 inhibits proliferation in human colon and lung carcinoma cells.
Lee JH; Park JW; Byun JK; Kim HK; Ryu PD; Lee SY; Kim DY
Oncotarget; 2015 Apr; 6(10):8132-43. PubMed ID: 25924237
[TBL] [Abstract][Full Text] [Related]
14. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
15. TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.
Guo H; Zhu H; Zhang J; Wan B; Shen Z
J Cell Biochem; 2019 Aug; 120(8):12559-12565. PubMed ID: 30825236
[TBL] [Abstract][Full Text] [Related]
16. [Expression of PSF1 in colon cancer tissues and its effect on the proliferation of colon cancer cells].
Wen JZ; Han XY; Wei B; Zhang S; Wei HB
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):70-4. PubMed ID: 23355245
[TBL] [Abstract][Full Text] [Related]
17. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer.
Dai Y; Qiao L; Chan KW; Yang M; Ye J; Zhang R; Ma J; Zou B; Lam CS; Wang J; Pang R; Tan VP; Lan HY; Wong BC
Mol Cancer Ther; 2009 Sep; 8(9):2762-70. PubMed ID: 19737940
[TBL] [Abstract][Full Text] [Related]
19. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
